Aperam SA (APAM)
Euronext Amsterdam · Netherlands · prices in EUR · close of 22 Oct 2026
Key indicators
| Last close | EUR 35.66 |
|---|---|
| 52-week range | 29.50 – 53.85 |
| Return, 1 month / 3 months | −20.4% / −24.1% |
| Return, 1 year / 3 years | +14.2% / +71.8% |
| Trend | Below its 200-day average |
| RSI (14) | 23 |
| Volatility (1 year) | 41.8% |
| Worst drawdown (1 year) | -32.1% |
| Average daily value traded | 5.14M EUR |
| Dividend yield | 5.6% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Aperam is a stainless and specialty steel maker based in Luxembourg. It produces stainless steel, electrical steel and nickel alloys, along with related services such as processing and distribution. Its customers are industrial manufacturers and other businesses that need corrosion-resistant and high-performance metals, and it serves markets across Europe, the Americas and Asia. The company operates mills and service centres and supplies flat and long products to sectors including automotive, construction, appliances and energy.
On this site Aperam SA appears as a stock on the Euronext Amsterdam (Netherlands), code APAM, with prices in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Aperam SA (APAM) trades on the Euronext Amsterdam in Netherlands. It last closed at EUR 35.66 on 22 October 2026.
Its price-based Market X-Ray is 45 out of 100 (a weak price profile), ranking 71 of 109 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 14.2% and over the last three months it fell 24.1%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Euronext Amsterdam
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 33 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -16.3% | ||
| From 52-week high | -32.8% | ||
| Momentum | 41 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -24.1% | ||
| 6-month return | -12.0% | ||
| 12-month return, skipping the last month | 43.6% | ||
| Stability (higher is calmer) | 30 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 41.8% | ||
| Worst drawdown, 1 year (smaller is calmer) | -32.1% | ||
| Liquidity | 64 · Fair | Moderate trading activity. | |
| Average daily value traded | 5.14M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 89 · Strong | Dividend is high and has been paid regularly. | |
| Dividend yield | 5.6% | ||
| Years with dividends | 6 |
Strengths
- Income: Dividend is high and has been paid regularly.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | −5.3% |
|---|---|
| 1 month | −20.4% |
| 3 months | −24.1% |
| 6 months | −12.0% |
| 1 year | +14.2% |
| 3 years | +71.8% |
| 5 years | +0.7% |
Signals
| 50-day / 200-day average | 43.60 / 42.60 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.40 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 13 Nov 2026 | EUR 0.5000 |
| 13 Aug 2026 | EUR 0.5000 |
| 21 May 2026 | EUR 0.5000 |
| 24 Feb 2026 | EUR 0.5000 |
| 17 Nov 2025 | EUR 0.5000 |
| 15 Aug 2025 | EUR 0.5000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Euronext Amsterdam; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.